101745648
voted
Morning mooers! It's Tuesday, June 11th. The market hit highs yesterday and is pulling back, the story of June so far.
My name is Kevin Travers, here are stories from the herd on Wall Street today.
$Apple (AAPL.US)$ was the highest gainer on the S&P 500 and Dow up about 3% after investors sold the news Monday when the firm announced Apple Intelligence- upgrades to Sirir that use GTP 4 to help answer questions a...
My name is Kevin Travers, here are stories from the herd on Wall Street today.
$Apple (AAPL.US)$ was the highest gainer on the S&P 500 and Dow up about 3% after investors sold the news Monday when the firm announced Apple Intelligence- upgrades to Sirir that use GTP 4 to help answer questions a...
40
7
2
101745648
commented on
$iShares Bitcoin Trust (IBIT.US)$ anyone knows how the management fees are charged? it is an annual fee or charged as part of the transaction fees?
2
101745648
voted
The markets experienced quite a rollercoaster after the latest Consumer Price Index (CPI) data came in higher than expected. Initially, this didn't seem like good news, and while the markets did recover somewhat, the majority of stocks still ended up lower. Surprisingly, almost 70% of Nasdaq stocks closed down even though the QQQ, an index that tracks some of the largest tech companies, finished positively. So, what caused this turnaround despite the high CPI numbers...
9
1
101745648
voted
The start of 2024 saw a quick drop in the stock market. This happened because many people got too comfortable with the gains they saw at the end of last year. It's always tough to lose some of the profits you've made, but it's even tougher if you bought stocks late when they were already high. Avoiding common mistakes can really help you stay ahead in the market. You can tell that people quickly switched from being eager to buy (FOMO) to being scared (FEAR) by look...
22
1
101745648
commented on
$Netlist (NLST.US)$ final judgement in vs Samsung. 303 million plus interest and lawyer fees. next up Micron
5
4
101745648
voted
Research Reveals Impact of Eli Lilly's Weight Loss Drug Rebound:
A study indicates that a year after discontinuing Eli Lilly's weight loss drug Zepbound, participants who had previously taken it for eight months experienced a slow rebound in weight, with half of the lost weight regained.
As a result, Eli Lilly's stock price took a dive at the opening of the U.S. stock market, experiencing an overall drop of 3.8% on that day, hitting a new low of $574.91. Novo Nordisk's st...
A study indicates that a year after discontinuing Eli Lilly's weight loss drug Zepbound, participants who had previously taken it for eight months experienced a slow rebound in weight, with half of the lost weight regained.
As a result, Eli Lilly's stock price took a dive at the opening of the U.S. stock market, experiencing an overall drop of 3.8% on that day, hitting a new low of $574.91. Novo Nordisk's st...
6